Sinopharm Modern: the wholly-owned subsidiary passed the GMP compliance inspection

2022-04-18 0 By

Sinopharm Modern co., LTD. (600420) : This GMP compliance inspection was conducted for the new quetiapine fumarate production line and midazolam production line in the API workshop of Langfang Branch of Sinopharm Group Industry Co., LTD., with a total equipment investment of about 988,000 yuan.All related products have passed the technical evaluation of the Drug Evaluation Center of the National Medical Products Administration, and their registration numbers have changed to “A” status on the registration information disclosure platform for API, pharmaceutical excipients and pharmaceutical packaging materials.